Key facts
- It has raised $8.0M; the latest was Seed Round ($6.0M) in Jan 2026.
- Notable investors include Bling Capital, nvp capital, Daybreak Ventures, Daybreak (New York).
- Status: Privately Held (backing).
Leadership
- Ralph HorwitzChief Medical Officer
- Liam GordonExecutive & Founder
- Sara DwyerChief Executive Officer & Founder
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Parambil
- ·The full record, as it builds
Funding rounds
No funding rounds for Parambil are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Parambil
Developer of an AI-powered legal tech company designed to revolutionize case preparation, insights and outcomes related to litigations. The company's platform is focused on delivering high-quality medical record analysis and litigation support to law firms, insurance companies, and in-house teams involved in mass torts, personal injury, and catastrophic cases, enabling the legal industry to improve its medical record curation and analysis.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2023
- Website
- parambil.com/
- Ownership
- Privately Held (backing)
Parambil doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Parambil shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Parambil in its N-PORT filings yet. We sweep new filings monthly.